-
公开(公告)号:US06806274B1
公开(公告)日:2004-10-19
申请号:US10019945
申请日:2002-01-07
申请人: Graham C Crawley , Laurent F A Hennequin , Darren McKerrecher , Patrick Ple , Jeffrey Philip Poyser , Christine M P Lambert
发明人: Graham C Crawley , Laurent F A Hennequin , Darren McKerrecher , Patrick Ple , Jeffrey Philip Poyser , Christine M P Lambert
IPC分类号: A61K31517
CPC分类号: C07D231/12 , C07D215/54 , C07D233/56 , C07D239/94 , C07D249/08 , C07D401/12 , C07D403/12 , C07D417/12 , C07D487/04
摘要: The invention concerns quinazoline derivatives of Formula (I) wherein Q1 includes a quinazoline ring optionally substituted with a group such as halogeno, trifluoromethyl and cyano, or a group of the formula: Q3—X1— wherein X1 includes a direct bond and O and Q3 includes aryl, aryl-(1-6C)alkyl, heterocyclyl and heterocyclyl-(1-6C)alkyl; each of R2 and R3 is hydrogen or (1-6C)alkyl; Z includes O, S and NH; and Q2 includes aryl and aryl-(1-3C)alkyl or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions in a warm-blooded animal.
摘要翻译: 本发明涉及式(I)的喹唑啉衍生物,其中Q 1包括任选被诸如卤代,三氟甲基和氰基的基团取代的喹唑啉环,或下式:Q 3 -X 1 - 的基团,其中 X 1包括直接键,O和Q 3包括芳基,芳基 - (1-6C)烷基,杂环基和杂环基 - (1-6C)烷基; R 2和R 3各自为氢或(1-6C)烷基; Z包括O,S和NH; 和Q 2包括芳基和芳基 - (1-3C)烷基或其药学上可接受的盐; 其制备方法,含有它们的药物组合物及其在制备用于预防或治疗温血动物中的T细胞介导的疾病或医学病症的药物中的用途。